BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29267283)

  • 1. FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas.
    Milewski D; Balli D; Ustiyan V; Le T; Dienemann H; Warth A; Breuhahn K; Whitsett JA; Kalinichenko VV; Kalin TV
    PLoS Genet; 2017 Dec; 13(12):e1007097. PubMed ID: 29267283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.
    Kim IM; Ackerson T; Ramakrishna S; Tretiakova M; Wang IC; Kalin TV; Major ML; Gusarova GA; Yoder HM; Costa RH; Kalinichenko VV
    Cancer Res; 2006 Feb; 66(4):2153-61. PubMed ID: 16489016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors.
    Wang IC; Meliton L; Tretiakova M; Costa RH; Kalinichenko VV; Kalin TV
    Oncogene; 2008 Jul; 27(30):4137-49. PubMed ID: 18345025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
    Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
    J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway.
    Wang K; Zhu X; Zhang K; Zhu L; Zhou F
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):804-9. PubMed ID: 27521795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL.
    Wei P; Zhang N; Wang Y; Li D; Wang L; Sun X; Shen C; Yang Y; Zhou X; Du X
    Int J Biol Sci; 2015; 11(2):186-98. PubMed ID: 25561901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
    Maeda Y; Tsuchiya T; Hao H; Tompkins DH; Xu Y; Mucenski ML; Du L; Keiser AR; Fukazawa T; Naomoto Y; Nagayasu T; Whitsett JA
    J Clin Invest; 2012 Dec; 122(12):4388-400. PubMed ID: 23143308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HOXC-AS3 facilitates the progression of invasive mucinous adenocarcinomas of the lung via modulating FUS/FOXM1.
    Yang Z; Hu T
    In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):15-23. PubMed ID: 31925650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
    Su J; Wu S; Wu H; Li L; Guo T
    Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
    Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
    Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
    Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
    Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.
    Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH
    Cancer Res; 2006 Feb; 66(3):1712-20. PubMed ID: 16452231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cancer cell stemness in glioma through glycolysis and the long noncoding RNA HULC-activated FOXM1/AGR2/HIF-1α axis.
    Li YP; Liu Y; Xiao LM; Chen LK; Tao EX; Zeng EM; Xu CH
    Lab Invest; 2022 Jul; 102(7):691-701. PubMed ID: 35013529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis.
    Zhao L; Liu L; Dong Z; Xiong J
    Oncol Rep; 2017 Dec; 38(6):3522-3530. PubMed ID: 29130108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis.
    Wang IC; Meliton L; Ren X; Zhang Y; Balli D; Snyder J; Whitsett JA; Kalinichenko VV; Kalin TV
    PLoS One; 2009 Aug; 4(8):e6609. PubMed ID: 19672312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis.
    Chen PM; Cheng YW; Wang YC; Wu TC; Chen CY; Lee H
    Neoplasia; 2014 Nov; 16(11):961-71. PubMed ID: 25425970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.
    Wang Y; Zhang W; Wen L; Yang H; Wen M; Yun Y; Zhao L; Zhu X; Tian L; Luo E; Li Y; Liu W; Wen N
    Oncotarget; 2016 Sep; 7(37):59245-59259. PubMed ID: 27494877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CENPE promotes lung adenocarcinoma proliferation and is directly regulated by FOXM1.
    Shan L; Zhao M; Lu Y; Ning H; Yang S; Song Y; Chai W; Shi X
    Int J Oncol; 2019 Jul; 55(1):257-266. PubMed ID: 31115500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers.
    Duruisseaux M; Antoine M; Rabbe N; Rodenas A; Mc Leer-Florin A; Lacave R; Poulot V; Duchêne B; Van Seuningen I; Cadranel J; Wislez M
    Lung Cancer; 2017 Jul; 109():92-100. PubMed ID: 28577958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.